Epstein-Barr Virus
Epstein-Barr virus studied, specific sites on origin of replication required
Published in Gene Therapy Weekly, January 6th, 2005
"Binding of the BZLF1 viral transactivator to Epstein-Barr virus (EBV) oriLyt has been reported to be essential for viral DNA replication," wrote R. Feederle and colleagues, German Cancer Research Center.
"We have constructed a recombinant virus (E2-oriLyt-R) in which the oriLyt BZLF1-binding sites (ZRE) were exchanged against papilloma E2-binding sites. A fusion protein between the BZLF1 protein-transactivating domain and the E2 protein-binding domain was able to reactivate...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-01-06)
More Articles from Gene Therapy Weekly
- Antisense Technology
XIAP protein inhibition sensitizes cancer cells to chemotherapy - Biodistribution
Dendritic poly(L-lysine) lengthens tumor retention of plasmid DNA - Prodrug
Flt3 ligand augments suicide gene therapy in a murine colon cancer model - Vector Development
Dendritic cell-based helper-dependent vectors limit antiviral activity - Virology
Vector toxicity confounds herpes simplex virus-mediated gene delivery - Awards
World Economic Forum selects 20 Technology Pioneers for 2005 - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
